The urolithiasis management devices market is estimated to be valued at US$ 1,694.7 Mn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The urolithiasis management devices market consists of medical devices used for the treatment of kidney stones. Some key products in the market include lithotripters, ureteral stents, nephrostomy catheters, and others. Technological advancements such as the development of digital lithotripters and miniaturized ureteroscopes are fueling the adoption of these devices.

Market Dynamics:
The growth of the urolithiasis management devices market is driven by increasing prevalence of kidney stones and technological advancements in devices. According to the National Kidney Foundation, around 10% to 15% of the world's population will likely develop kidney stones at some point. Advancements such as digital lithotripters offer improved imaging capabilities and precise stone fragmentation compared to conventional lithotripters. Similarly, miniaturized ureteroscopes allow treatment of more complex stones in a less invasive manner.

SWOT Analysis

Strength: Lumenis Ltd., Boston Scientific Corp, BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc, Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH are leading players in this market with strong brand reputation and product portfolios. The growing acceptance of minimally invasive procedures drives the adoption of advanced urolithiasis management devices. Rising awareness regarding kidney stone treatment boosts the market growth.

Weakness: High cost of lithotripsy procedures limits the affordability in low-income countries. Lack of skilled professionals for operating specialized devices poses operational challenges.

Opportunity: Untapped opportunities in emerging Asian and Latin American markets due to increasing healthcare expenditures. Launch of innovative laser and ultrasound technologies with improved effectiveness and safety offers lucrative growth prospects.

Threats: Stringent regulatory approvals and reimbursement policies prolong the product launch timelines. Substitutes like pharmaceutical drug therapies threaten the market dominance of device-based treatment modalities.


Key Takeaways

The global urolithiasis management devices market is expected to witness high growth, exhibiting CAGR of 4.8% over the forecast period, due to increasing prevalence of kidney stone disease and rising geriatric population.

Regional analysis

North America dominates the global market, owing to the rising incidence of kidney stones, favorable reimbursements, and availability of advanced technologies. Asia Pacific is poised to grow at the fastest rate during the forecast period due to growing medical tourism, increasing healthcare spending, and rising awareness regarding urolithiasis treatment.

Key players

Key players operating in the urolithiasis management devices market are Lumenis Ltd., Boston Scientific Corp, BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc, Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group., HealthTronics, Inc., CONMED Corporation., Applaud Medical, Inc., Potent Medical., and other prominent players